Document is current
Any future updates will be listed below
-
Authors
Chehaibou, Ismael
Pettenkofer, Moritz
Govetto, Andrea
Rabina, Gilad
Sadda, SriniVas R.
Hubschman, Jean-Pierre https://orcid.org/0000-0002-8631-3467
-
Funding
Funding for this research was provided by:
Research to Prevent Blindness
Hess Foundation
- License Information
-
More Information
Article History
Received: 22 April 2020
Accepted: 29 June 2020
First Online: 10 July 2020
Ethics approval and consent to participate
: This research study was conducted retrospectively from data obtained for clinical purposes. An IRB official waiver of ethical approval was granted from the University of California Los Angeles Office of Human Research Protection (IRB#16-000574).
: Not applicable.
: Jean-Pierre Hubschman: Alcon (C), Allergan (C), Bausch and Lomb (C), Novartis (C), Carl Zeiss Meditec (C); SriniVas R. Sadda: Amgen (C), Allergan (C), Carl Zeiss Meditec (F), CenterVue (C), Genentech (C), Heidelberg engineering (C,F), 4DMT (C), Novartis (C), Optos (C), Oxurion (C), Samsung Biopses (C). The following authors have no financial disclosures: Ismael Chehaibou; Moritz Pettenkofer; Andrea Govetto; Gilad Rabina.
